TOP 10 TAKEAWAYS FROM THE US SUPREME COURT RULING REGARDING TRANSGENDER AFFIRMING CARE

The Supreme Court's ruling in United States v. Skrmetti marks a significant and concerning development from the perspective of transgender people, particularly transgender minors and their families. By upholding Tennessee's Senate Bill 1 (SB1), a law restricting sex transition treatments for minors, the Court has issued a decision that fundamentally alters the landscape of legal protections and access to healthcare for this community. The ruling's implications extend far beyond Tennessee, setting a precedent that deeply impacts the rights and well-being of transgender individuals across the United States.

Here are the top 10 important takeaways from the ruling from the perspective of transgender people:

1. Upholding Bans on Gender-Affirming Care for Minors: The most immediate and direct impact is the Supreme Court's affirmation of Tennessee's SB1, which prohibits healthcare providers from prescribing, administering, or dispensing puberty blockers or hormones to minors for the purpose of enabling them to identify with an identity inconsistent with their biological sex, or treating discomfort related to such a discordance. This outcome means that states now have a clearer path to implement and enforce similar categorical bans on gender-affirming medical care for minors, potentially forcing families to leave their home states or forgo essential medical treatment.

   
   

2. Denial of Heightened Judicial Scrutiny: The Court explicitly ruled that SB1 is not subject to heightened scrutiny under the Equal Protection Clause of the Fourteenth Amendment. This is a critical blow, as heightened scrutiny (intermediate or strict) typically applies to laws that classify individuals based on protected characteristics, such as sex or race, requiring states to provide an "exceedingly persuasive justification." By instead applying rational basis review—the lowest level of judicial review—the Court demands little more than a "reasonably conceivable state of facts" to uphold the law, making it significantly easier for states to enact and defend similar legislation.

   
   

3. Rejection of Sex-Based Classification in the Law: The Court held that SB1 does not classify based on sex, despite arguments from plaintiffs and dissenting justices that it clearly differentiates treatment based on biological sex. The majority reasoned that the law prohibits specific medical uses (treating gender dysphoria) for minors, regardless of their sex, rather than distinguishing between sexes for the same treatment. From a transgender perspective, this ruling effectively allows laws to create sex-based distinctions in practice (e.g., a male minor can receive hormones to look more masculine, but a female minor cannot to look more masculine to align with their identity) without triggering the more rigorous review typically afforded to sex discrimination.

   
   

4. Denial of "Suspect" or "Quasi-Suspect" Class Status for Transgender Individuals: The Court declined to recognize transgender status as a suspect or quasi-suspect class. This decision reinforces that laws classifying individuals based on their transgender status will generally be subject to rational basis review, meaning they are presumed constitutional unless proven to lack any rational relation to a legitimate government interest. This is a setback for advocates who argued that transgender individuals, given their history of discrimination and political powerlessness, deserve heightened judicial protection similar to other marginalized groups.

   
   

5. Narrowing the Scope of Bostock v. Clayton County: The Court explicitly stated that it did not need to consider whether the reasoning from Bostock (which found discrimination against gay and transgender employees to be sex discrimination under Title VII) extended beyond the Title VII context. Even if it did, the majority argued, Bostock's "but-for causation" test would not apply because changing a minor's sex or transgender status would not alter SB1's application if they lack a "qualifying diagnosis" unrelated to gender dysphoria. This interpretation limits a key precedent that had been viewed as foundational for broader LGBTQ+ rights, suggesting its principles might not readily apply to equal protection challenges outside of employment.

   
   

6. Validation of State Concerns Over Medical Uncertainty and Minor Maturity: The Court accepted Tennessee's rationales for SB1, including concerns about the risks of gender-affirming treatments (such as irreversible sterility, increased risk of disease, and adverse psychological consequences), the experimental nature of such procedures, and the belief that minors lack the maturity to understand the "life-altering consequences" or may later express regret. This grants states broad discretion to legislate in areas of "medical and scientific uncertainty," legitimizing legislative decisions that override established medical consensus among major professional organizations.

   
   

7. Dismissal of Sex Stereotyping Allegations: The Court rejected the argument that SB1 enforces a government preference that people conform to expectations about their sex, stating that any allegations of sex stereotyping were "misplaced". It interpreted Tennessee's stated interest in "encouraging minors to appreciate their sex" as reflecting concerns about the risks of treatments rather than an impermissible motive to enforce gender conformity. This outcome suggests that challenging laws on sex-stereotyping grounds will be complicated when legislatures articulate other seemingly neutral motivations.

   
   

8. Increased Vulnerability to State-Sanctioned Discrimination: By allowing laws like SB1 to pass with only rational basis review, the ruling makes it significantly easier for states to enact discriminatory legislation targeting transgender individuals. The dissenting justices warned that this decision "abandons transgender children and their families to political whims" and allows legislatures to engage in discrimination by "hiding blatant sex classifications in plain sight". This creates a climate of uncertainty and fear for transgender people and their families, as their access to care and legal recognition may depend on the political climate of their state.

   
   

9. Erosion of Equal Protection Principles for Minorities: The dissenting opinions argued that the majority's decision does "irrevocable damage to the Equal Protection Clause". They contended that the Court's refusal to apply meaningful judicial review to a law that so clearly classifies based on sex and transgender status undermines the Constitution's bedrock guarantee of equal protection, particularly for "discrete and insular minorities" who rely on judicial review to safeguard their rights against majoritarian political processes. This could set a concerning precedent for other marginalized groups seeking constitutional protection.

   
   

10. Legitimization of Distrust in Mainstream Medical Expertise: Justice Thomas's concurring opinion, in particular, strongly criticized the notion of "medical consensus" regarding gender-affirming care, arguing that "so-called experts have no license to countermand the 'wisdom, fairness, or logic of legislative choices'". He highlighted the "shifting scientific landscape" and "recent revelations" suggesting that organizations like WPATH base their guidance on "insufficient evidence" and allow "ideology to influence their medical guidance." From the perspective of transgender people and their supportive healthcare providers, this fuels skepticism towards established medical protocols and professional organizations, making it harder to advocate for evidence-based care and exacerbating an already contentious public debate.

    
    

In essence, the Supreme Court's decision in United States v. Skrmetti represents a profound legal and social setback for transgender people. It diminishes judicial protections against discrimination, grants states broad authority to restrict essential healthcare, and entrenches the idea that laws based on gender identity may not warrant rigorous constitutional scrutiny, leaving transgender individuals in a precarious position regarding their rights and access to life-saving care.